Abstract
Rheumatoid arthritis (RA) is a systemic autoimmune disease that is characterized by chronic synovial inflammation. Patients with RA have increased risk of infection; this is related to RA itself or the adverse effects of medication. In this report, we describe a case of emphysematous pyelonephritis in a patient with RA associated with AA amyloidosis and steroid-induced diabetes mellitus who was taking corticosteroid and low-dose methotrexate.
MeSH terms
-
Aged
-
Amyloidosis / complications
-
Amyloidosis / immunology
-
Amyloidosis / pathology
-
Arthritis, Rheumatoid / complications*
-
Arthritis, Rheumatoid / drug therapy
-
Arthritis, Rheumatoid / immunology
-
Diabetes Mellitus / chemically induced
-
Dose-Response Relationship, Drug
-
Emphysema / etiology*
-
Emphysema / immunology
-
Emphysema / pathology
-
Female
-
Glucocorticoids / adverse effects*
-
Humans
-
Immunocompromised Host
-
Immunosuppressive Agents / adverse effects*
-
Methotrexate / adverse effects*
-
Pyelonephritis / etiology*
-
Pyelonephritis / pathology
-
Serum Amyloid A Protein / analysis
Substances
-
Glucocorticoids
-
Immunosuppressive Agents
-
Serum Amyloid A Protein
-
Methotrexate